Life Scientist > Biotechnology

How do antidepressants treat nerve pain?

04 May, 2022

Knowing how pain impulses are inhibited by tricyclic antidepressants is expected to lead to new and improved treatment options.

Biobanking could save koalas from extinction

26 April, 2022

Biobanking and assisted reproduction could become a reality for koalas by leveraging the existing technology used to help humans conceive.

CA inhibitor drug reduces breathing pauses in sleep apnoea

21 April, 2022

Overall, the treatment reduced the number of breathing pauses and promoted oxygenation during the night.

Accelerating Australia's RNA Capabilities

19 April, 2022

It is one thing to invest into pure research, but to invest in a future that has, at its core, collaboration and accelerated development is a giant leap.

Creating a genetic medicine manufacturing ecosystem: part 3

07 April, 2022 by Peter Davis

A year ago, we were waiting for the federal government to deliver funding and a plan forward for a genetic medicine ecosystem.

'Trojan Horse' drug delivery system developed

05 April, 2022

Scientists created a method of delivering drugs into human cells using large biological molecules by first encasing them in a protein-based microdroplet.

Clinical trial commences for Melbourne-made COVID vaccines

29 March, 2022

Researchers are looking for 114 healthy people aged 18–70 living in Victoria to roll up their sleeves for a Phase 1 clinical trial of two Melbourne-made COVID-19 vaccines.

Winter COVID booster for at-risk groups, Vic to make mRNA vaccines

25 March, 2022

ATAGI recommends an additional booster dose of COVID-19 vaccine for vulnerable population groups, and Moderna agrees to produce up to 100 million Australian-made mRNA vaccine doses every year.

CRISPR cancer therapy doesn't kill healthy cells

14 March, 2022

Researchers have combined the concepts of cancer genomics and CRISPR-Cas9 to propose a cancer therapy that kills cancer cells without affecting normal tissues.

HEK cells vs CHO cells: what's the better choice?

07 March, 2022

Due to the many possibilities as well as advantages and disadvantages, it can be quite troubling to decide which cells would serve specific research the best.

Moderna COVID-19 vaccine approved for kids 6–11

23 February, 2022

The Australian Government has accepted advice to make the Moderna COVID-19 vaccine available for children aged six years and older from 24 February 2022.

More efficient method for creating sulfur-based medicines

21 February, 2022

Scientists say their method gives rise to a series of sulfur-based pharmacophores with enough variation to make the drug discovery process more efficient and fruitful.

One dose of anti-parasite drug effective at reducing scabies

16 February, 2022

One dose of ivermectin was not inferior to two doses, taken a week apart, for reducing scabies prevalence in Fiji.

'Bionic' pacemaker reinstates heart rate variability

09 February, 2022

Researchers from The University of Auckland have designed a pacemaker that re-establishes the heart's naturally irregular beat.

Lumos set to manufacture rapid antigen tests in Victoria

03 February, 2022

Lumos Diagnostics has agreed to establish a manufacturing facility and innovation hub in Victoria, which will help the state to secure critical supplies of RATs.

  • All content Copyright © 2022 Westwick-Farrow Pty Ltd